The biosurgical agent market in Europe is primarily driven by growing surgical procedure volumes, rising awareness of the benefits of these products in surgical outcomes, and the introduction of new products with enhanced features and expanded indications. However, the European market continues to be limited by a lack of reimbursement for biosurgical agents, growing concerns over product cost and reluctance to use products derived from human tissue among some physicians and patients, hindering the pace of market growth.
This Medtech 360 Report provides high-level market metrics for biosurgical agents in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
Table of contents
- Biosurgical Agents - Market Insights - Europe (Supplemental)
Author(s): Muskan Kishore, MBA(Pharm)
Muskan Kishore is a market expert specializing in gastrointestinal endoscopy devices within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group. Muskan Kishore holds a Bachelor's degree in Pharmacy from Panjab University, Chandigarh, and an MBA (Pharm) from the National Institute Of Pharmaceutical Sciences And Research (Mohali), Punjab.